ROBYN WOLKOFSKY: Open Payments
NPI 1003840943 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 16 payments from 9 companies in 2025. Trend: 2023 $409 · 2024 $769 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Medicure Pharma Inc. | 1 | $190 |
| ABBVIE INC. | 4 | $90 |
| Lilly USA, LLC | 2 | $82 |
| PFIZER INC. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Merz Pharmaceuticals, LLC | 1 | $34 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| Lundbeck LLC | 1 | $21 |
| ACADIA Pharmaceuticals Inc | 1 | $21 |
Products named: Zypitamag, VYALEV, KISUNLA, NURTEC ODT, INGREZZA, Xeomin, CREXONT, REXULTI.
Industry payments across NC — which companies pay providers there.
